Cargando…
SARS-CoV-2 infection increases the gene expression profile for Alzheimer’s disease risk
The coronavirus disease 2019 (COVID-19) pandemic has caused over 600,000,000 infections globally thus far. Up to 30% of individuals with mild to severe disease develop long COVID, exhibiting diverse neurologic symptoms including dementias. However, there is a paucity of knowledge of molecular brain...
Autores principales: | Green, Ryan, Mayilsamy, Karthick, McGill, Andrew R., Martinez, Taylor E., Chandran, Bala, Blair, Laura J., Bickford, Paula C., Mohapatra, Shyam S., Mohapatra, Subhra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508696/ https://www.ncbi.nlm.nih.gov/pubmed/36187720 http://dx.doi.org/10.1016/j.omtm.2022.09.007 |
Ejemplares similares
-
Acetate-encapsulated Linolenic Acid Liposomes Reduce SARS-CoV-2 and RSV Infection
por: McGill, Andrew R., et al.
Publicado: (2023) -
Ultrafast-UV laser integrating cavity device for inactivation of SARS-CoV-2 and other viruses
por: Ambardar, Sharad, et al.
Publicado: (2022) -
Identification of SARS-CoV-2 Spike Palmitoylation Inhibitors That Results in Release of Attenuated Virus with Reduced Infectivity
por: Ramadan, Ahmed A., et al.
Publicado: (2022) -
Combination Therapy of Mithramycin A and Immune Checkpoint Inhibitor for the Treatment of Colorectal Cancer in an Orthotopic Murine Model
por: Dutta, Rinku, et al.
Publicado: (2021) -
SARS-CoV-2-Induced Gut Microbiome Dysbiosis: Implications for Colorectal Cancer
por: Howell, Mark C., et al.
Publicado: (2021)